129 related articles for article (PubMed ID: 4055052)
1. An overview of cefotaxime therapy in infections caused by gram-positive pathogens.
Iannini PB
Infection; 1985; 13 Suppl 1():S3-6. PubMed ID: 4055052
[TBL] [Abstract][Full Text] [Related]
2. A review of the use of cefotaxime in the treatment of skin and skin structure infections, with special reference to gram-positive pathogens.
Karakusis PH; Trenholme GM; Levin S
Infection; 1985; 13 Suppl 1():S46-9. PubMed ID: 4055055
[TBL] [Abstract][Full Text] [Related]
3. Experience with cefotaxime in infections caused by gram-positive pathogens, especially Staphylococcus aureus.
Fujii R
Infection; 1985; 13 Suppl 1():S9-13. PubMed ID: 4055062
[TBL] [Abstract][Full Text] [Related]
4. Cefotaxime and cephalosporins: adverse reactions in perspective.
Smith CR
Rev Infect Dis; 1982; 4 Suppl():S481-8. PubMed ID: 6294802
[TBL] [Abstract][Full Text] [Related]
5. The use of cefotaxime in the treatment of gram-positive pneumonias.
Jenkinson SG
Infection; 1985; 13 Suppl 1():S14-7. PubMed ID: 4055045
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience of cefotaxime in infections caused by gram-positive pathogens.
Bassetti D; Solbiati M; Fraizzoli G
Infection; 1985; 13 Suppl 1():S112-4. PubMed ID: 4055040
[TBL] [Abstract][Full Text] [Related]
7. Cefotaxime for the treatment of gram-positive urinary tract infection.
Piccinno A; Pagliarulo A
Infection; 1985; 13 Suppl 1():S100-2. PubMed ID: 4055038
[TBL] [Abstract][Full Text] [Related]
8. Cefotaxime: efficacy and tolerance in lower respiratory tract infections caused by gram-positive cocci.
Lode H; Glatzel PD
Infection; 1985; 13 Suppl 1():S25-7. PubMed ID: 4055050
[TBL] [Abstract][Full Text] [Related]
9. Use of cefotaxime, a beta-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms.
Francke EL; Neu HC
Am J Med; 1981 Sep; 71(3):435-42. PubMed ID: 6269426
[TBL] [Abstract][Full Text] [Related]
10. [Bacteriological and clinical studies of cefodizime in pediatrics].
Akita H; Sato Y; Iwata S; Sunakawa K
Jpn J Antibiot; 1991 Apr; 44(4):398-411. PubMed ID: 1880919
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of cefotaxime in gram-positive surgical infections.
Wittmann DH; Frommelt L
Infection; 1985; 13 Suppl 1():S37-42. PubMed ID: 4055054
[TBL] [Abstract][Full Text] [Related]
12. Cefotaxime monotherapy of bacterial meningitis caused by gram-positive pathogens.
Helwig HF
Infection; 1985; 13 Suppl 1():S62-7. PubMed ID: 4055057
[TBL] [Abstract][Full Text] [Related]
13. Comparative clinical evaluation of imipenem/cilastatin vs. cefotaxime in treatment of severe bacterial infections.
Stamboulian D; Argüello EA; Jasovich A; Villar O; Maglio F
Rev Infect Dis; 1985; 7 Suppl 3():S458-62. PubMed ID: 3901208
[TBL] [Abstract][Full Text] [Related]
14. Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Richards DM; Heel RC
Drugs; 1985 Apr; 29(4):281-329. PubMed ID: 3888599
[TBL] [Abstract][Full Text] [Related]
15. Bone and joint infections caused by gram-positive bacteria: treatment with cefotaxime.
LeFrock J; Mader J; Smith B; Carr B
Infection; 1985; 13 Suppl 1():S50-5. PubMed ID: 4055056
[TBL] [Abstract][Full Text] [Related]
16. Clinical applications of a new parenteral antibiotic in the treatment of severe bacterial infections.
Holloway WJ; Palmer D
Am J Med; 1996 Jun; 100(6A):52S-59S. PubMed ID: 8678098
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of pathogenic bacteria and drug resistance in neonatal purulent meningitis].
Zhu M; Hu Q; Mai J; Lin Z
Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):51-6. PubMed ID: 25748405
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of the effect of cefotaxime in senile pneumonia caused by gram-positive and gram-negative bacteria.
Katsunuma H
Infection; 1985; 13 Suppl 1():S18-24. PubMed ID: 4055049
[TBL] [Abstract][Full Text] [Related]
19. Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.
Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1983 Mar; 25(3):223-89. PubMed ID: 6303743
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of cefotaxime in serious infections.
Karakusis PH; Feczko JM; Goodman LJ; Hanlon DM; Harris AA; Levin S; Trenholme GM
Antimicrob Agents Chemother; 1982 Jan; 21(1):119-24. PubMed ID: 6282202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
